Edesa anticipates topline results could be available within as few as 12 to 18 months following regulatory clearance by the FDA. Health Canada has previously granted approval to initiate this Phase 2 ...

TORONTO - Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, has announced the completion of a private placement funding round on February 12, 2025, raising approximately ...

Financing led by Velan Capital with participation from new and existing healthcare-focused institutional investors and insidersCapital raise to ...

Ben's parents Allyn and Jenny have said they would not have cremated their son if they knew there were questions over his ...

A Health Services Safety Investigations Body report, published this fortnight, examined deaths in inpatient mental health ...

The Weston parents of a premature baby have told a fresh inquest into his death that a hospital “covering up” failings has had a ...

The father of a baby who died in hospital claims doctors "intentionally" did not disclose his son had a fatal infection until ...

In June 2016, an inquest recorded Ben's death as being caused by acute respiratory distress syndrome (ARDS), metapneumovirus ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for ...

Acute respiratory distress syndrome (ARDS) is present in >10% of all people admitted to critical care and is associated with severe morbidity and mortality. Despite more than half a century since its ...

The National Kidney Foundation (NKF) has awarded Kathleen Liu, MD, Professor of Medicine and Anesthesia in the Divisions of Nephrology and Critical Care Medicine; Medical Director of the Medical ...